(NaturalNews) At first glance, a study just published in the August 19th edition of the
Journal of the American Medical Association (JAMA) is yet another whitewash job about the safety of the quadrivalent human papillomavirus recombinant vaccine --better known as Gardasil, the genital human papillomavirus (HPV) vaccine. Licensed in June of 2006 by the Food and Drug Administration (FDA) for girls and young women between the ages of nine and 26, the enormously hyped and advertised vaccine is designed to prevent
infection with four types of
HPV: types 16 and 18 can cause cervical
cancer and types 6 and 11 are the most common types of genital warts.
The
JAMA report says that the
Gardasil adverse events reported have been mostly consistent with data gathered before the
vaccine was considered safe enough to be widely administered to young
girls. But a close reading shows some disturbing additional facts.
Just as
NaturalNews has consistently reported, the vaccine has caused an extraordinary number of adverse side effects (
http://www.naturalnews.com/026722_Gardasil_HPV_cervical_cancer.html). And now comes word from the
JAMA report that the
HPV vaccine has unexpectedly caused episodes of fainting and life-threatening
blood clots. In fact, in a statement to the media, these events were called "disproportional" -- meaning these
side effects are anything but rare.
What's more, among the 12,424 adverse reaction reports about the HPV vaccine, 772 (6.2 percent) were serious and included 32 reports of death. Other problems caused by the vaccine include local site reactions, skin rashes, nausea, dizziness, headaches and even Guillain-Barre syndrome (a disorder in which the body's immune system attacks part of the peripheral nervous system sometimes causing paralysis) and anaphylaxis (hypersensitivity reaction that can cause sudden death). As just reported by CBS news, the teenage daughter of physician Scott Ratner and his wife was one of the unfortunate girls who became severely ill with a chronic autoimmune disease, myofasciitis, after her first dose of Gardasil. Dr. Ratner told CBS his daughter was so ill with the neurological problem "..she'd have been better off getting cervical cancer than the vaccination."
One the lead researchers for Gardasil has also gone public this week, telling CBS news
there is no data showing that the vaccine even remains effective beyond five years. That means that if a ten year old girl is given the vaccine and subjected to possibly serious and even life-threatening side effects, the vaccine may offer her no
protection at all when she hits her teens or young adulthood.
What makes the debate about Gardasil crazy to begin with is that studies have shown 70 to 90 percent of people with HPV naturally clear the
virus from the body within two years of infection -- with no help from drugs or vaccines. So the most effective protection from problems caused by HPV is to avoid being infected by the multiple strains of HPV by not engaging in promiscuous, unprotected-by-condoms sex (the virus is transmitted sexually and condoms do not offer 100 percent protection) and by keeping your body's immune system strong and healthy through good nutrition, exercise and exposure to sunlight.
In an editorial accompanying the
JAMA study, Charlotte Haug, M.D., Ph.D., M.Sc., of The Journal of the Norwegian Medical Association in Oslo expressed her concerns about the aggressively promoted Gardasil vaccine: "Whether a
risk is worth taking depends not only on the absolute risk, but on the relationship between the potential risk and the potential benefit. If the potential benefits are substantial, most individuals would be willing to accept the risks. But the net benefit of the HPV vaccine to a woman is uncertain. Even if persistently infected with HPV, a woman most likely will not develop cancer if she is regularly screened..."
For more information:http://www.cbsnews.com/stories/2009/08/19/cbsnews_investigates/main52...http://www.indiana.edu/~health/hpv.htmlhttp://www.naturalnews.com/025613_cancer_HPV_cervical_cancer.html
Have comments on this article? Post them here:
people have commented on this article.
Email this article to a friend
Share this article on: 
Now Available from 
